Merit Medical Systems Stock Forecast, Price & News

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Merit Medical Systems stock.
View analyst ratings for Merit Medical Systems or view top-rated stocks.

Wall Street analysts have given Merit Medical Systems a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Merit Medical Systems wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Merit Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.
View our earnings forecast for Merit Medical Systems.

Merit Medical Systems, Inc. (NASDAQ:MMSI) announced its quarterly earnings results on Thursday, July, 29th. The medical instruments supplier reported $0.62 EPS for the quarter, topping analysts' consensus estimates of $0.44 by $0.18. The medical instruments supplier had revenue of $280.33 million for the quarter, compared to the consensus estimate of $251.40 million. Merit Medical Systems had a net margin of 2.74% and a trailing twelve-month return on equity of 12.42%.
View Merit Medical Systems' earnings history.

Merit Medical Systems' stock was trading at $32.88 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MMSI shares have increased by 117.7% and is now trading at $71.59.
View which stocks have been most impacted by COVID-19.

Merit Medical Systems updated its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share guidance of $2.070-$2.220 for the period, compared to the Thomson Reuters consensus estimate of $1.930. The company issued revenue guidance of $1.06 billion-$1.07 billion, compared to the consensus revenue estimate of $1.01 billion.

8 equities research analysts have issued 12-month price targets for Merit Medical Systems' stock. Their forecasts range from $60.00 to $83.00. On average, they anticipate Merit Medical Systems' stock price to reach $73.13 in the next year. This suggests a possible upside of 2.1% from the stock's current price.
View analysts' price targets for Merit Medical Systems or view top-rated stocks among Wall Street analysts.

158 employees have rated Merit Medical Systems CEO Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among Merit Medical Systems' employees.

Some companies that are related to Merit Medical Systems include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), DENTSPLY SIRONA (XRAY), STAAR Surgical (STAA), Quidel (QDEL), ICU Medical (ICUI), Neogen (NEOG), Haemonetics (HAE), Atrion (ATRI), Cerus (CERS), OraSure Technologies (OSUR), Meridian Bioscience (VIVO), Antares Pharma (ATRS) and Anika Therapeutics (ANIK).
View all of MMSI's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Merit Medical Systems' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (13.39%), Vanguard Group Inc. (10.00%), ArrowMark Colorado Holdings LLC (6.98%), William Blair Investment Management LLC (6.11%), Conestoga Capital Advisors LLC (4.20%) and State Street Corp (3.27%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, Brian G Lloyd, David Floyd, David Ming-Teh Liu, Enterprise Associates 14 New, Franklin J Miller, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Nolan E Karras, Raul Jr Parra and Ronald Frost.
View institutional ownership trends for Merit Medical Systems.

MMSI stock was sold by a variety of institutional investors in the last quarter, including Nuance Investments LLC, Massachusetts Financial Services Co. MA, ArrowMark Colorado Holdings LLC, BlackRock Inc., California Public Employees Retirement System, Aristotle Capital Boston LLC, Rockefeller Capital Management L.P., and Ziegler Capital Management LLC. Company insiders that have sold Merit Medical Systems company stock in the last year include A Scott Anderson, Brian G Lloyd, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Raul Jr Parra, and Ronald Frost.
View insider buying and selling activity for Merit Medical Systems or view top insider-selling stocks.

MMSI stock was bought by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Millennium Management LLC, Emerald Mutual Fund Advisers Trust, Invesco Ltd., Morgan Stanley, Morgan Stanley, Dimensional Fund Advisors LP, and Emerald Advisers LLC. Company insiders that have bought Merit Medical Systems stock in the last two years include David Floyd, Enterprise Associates 14 New, and Raul Jr Parra.
View insider buying and selling activity for Merit Medical Systems or or view top insider-buying stocks.

Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MMSI stock can currently be purchased for approximately $71.59.

Merit Medical Systems has a market capitalization of $4.03 billion and generates $963.88 million in revenue each year. The medical instruments supplier earns $-9,840,000.00 in net income (profit) each year or $1.65 on an earnings per share basis.

Merit Medical Systems employs 5,989 workers across the globe.

The following companies are subsidiares of Merit Medical Systems: Alveolus Inc., Argon Medical Devices Netherlands BV, BSMD Ventures Inc., BioSphere Medical Inc., BioSphere Medical Japan Inc., BioSphere Medical SA, Brightwater Medical Inc., Brightwater Medical Inc., Cianna Medical Inc., DFINE Inc., Dfine Europe GmbH, Fibrovein Holdings Limited, ITL Healthcare Pty Ltd., IntelliMedical Technologies Pty Ltd., LLC Merit Technologies, Merit Holdings Inc., Merit Maquiladora México S. DE R.L. DE C.V., Merit Medical (NRI) Ireland Limited, Merit Medical Africa (Pty) LTD, Merit Medical Asia Company Limited, Merit Medical Australia Pty Ltd., Merit Medical Austria GmbH, Merit Medical Beijing Co. Ltd., Merit Medical Belgium Sprl, Merit Medical Canada Ltd., Merit Medical Coatings B.V., Merit Medical Comercialização Distribuição Importação e Exportação de Produtos Hospitalares LTDA., Merit Medical Denmark A/S, Merit Medical Egypt LLC, Merit Medical Finland Ltd., Merit Medical France SAS, Merit Medical GmbH, Merit Medical Ireland Ltd., Merit Medical Italy S.R.L., Merit Medical Japan KK, Merit Medical Korea Co. Ltd., Merit Medical ME FZ-LLC, Merit Medical Malaysia Sdn. Bhd, Merit Medical Nederland B.V., Merit Medical New Zealand Limited, Merit Medical Norway AS, Merit Medical Portugal S.A., Merit Medical Singapore Holdings Pte. Ltd, Merit Medical Singapore Pte. Ltd., Merit Medical South Africa (Pty) LTD, Merit Medical Spain S.L.Unipersonal, Merit Medical Switzerland AG, Merit Medical Systems AB, Merit Medical Systems India Private Limited, Merit Medical System’s NRI Limited, Merit Medical Turkey Tıbbi Ürünler Ticaret Anonim Şirketi, Merit Medical UK Limited, Merit Mexico Sales S. de R.L. de C.V., Merit Sensor Systems Inc., STD Pharmaceutical (Ireland) Limited, STD Pharmaceutical Products Limited, Thomas Medical Products Inc., Vascular Access Technologies Inc., and Vascular Insights LLC.

Merit Medical Systems was founded in 1987.

The official website for Merit Medical Systems is www.merit.com.

Merit Medical Systems is headquartered at 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095.

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at (801) 253-1600 or via email at [email protected].